Melanoma Clinical Trials in Pittsburgh

Showing 261-280 of 329 trials

Dendritic Cells (DC) Vaccine for Metastatic Melanoma

NCT01042366

The purpose of this study is to determine what effect using an experimental tumor vaccine (a substance or group of substances meant to cause the immune system to respond to a tumor) made using patients' own tumor cells and blood cells will have on their melanoma.

Metastatic Melanoma

John Kirkwood16 participantsStarted Oct 2002

Pittsburgh, Pennsylvania, United States

TERMINATEDPhase 1/2< 1 mile

A Study of Varlilumab (Anti-CD27) and Ipilimumab and CDX-1401 in Patients With Unresectable Stage III or IV Melanoma

NCT02413827

This is a study to determine the clinical benefit (how well the drug works), safety and tolerability of combining a) varlilumab and ipilimumab and b) varlilumab, ipilimumab, CDX-1401 and poly-ICLC. The study will enroll patients with unresectable Stage III or Stage IV melanoma.

Unresectable Stage III or Stage IV Melanoma

Celldex Therapeutics9 participantsStarted Apr 2015

San Francisco, California, United States • Santa Rosa, California, United States • Aurora, Colorado, United States +5 more locations

Dendritic Cells (DC) Vaccine for Metastatic Melanoma

A Study of Varlilumab (Anti-CD27) and Ipilimumab and CDX-1401 in Patients With Unresectable Stage III or IV Melanoma

Melanoma Trials in Other Cities

Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma

Safety Study of Modified Vaccinia Virus to Cancer

Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma

Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung

Post-Approval Study of MelaFind

Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

Everolimus in Treating Patients With Stage IV Melanoma

A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)

Safety Study of PLX4032 in Patients With Solid Tumors

In Vivo Confocal Microscopy Study of Pigmented Conjunctival Lesions

Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma

A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma

SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma

Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)

Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients

Other Conditions in Pittsburgh